Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model

Por Telang, Sucheta, Clem, Amy L, Eaton, John W, Chesney, Jason
Publicado em 2007

Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers

Por Clem, Amy L, Sims, Jonathan, Telang, Sucheta, Eaton, John W, Chesney, Jason
Publicado em 2007

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

Por Telang, Sucheta, Clem, Brian F, Klarer, Alden C, Clem, Amy L, Trent, John O, Bucala, Richard, Chesney, Jason
Publicado em 2012

A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling

Por Clem, Brian F., Clem, Amy L., Yalcin, Abdullah, Goswami, Umesh, Arumugam, Sengodagounder, Telang, Sucheta, Trent, John O., Chesney, Jason
Publicado em 2011

Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase (PFKFB3)

Por Imbert-Fernandez, Yoannis, Clem, Brian F., O'Neal, Julie, Kerr, Daniel A., Spaulding, Robert, Lanceta, Lilibeth, Clem, Amy L., Telang, Sucheta, Chesney, Jason
Publicado em 2014

Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases

Por Yalcin, Abdullah, Clem, Brian F., Simmons, Alan, Lane, Andrew, Nelson, Kristin, Clem, Amy L., Brock, Erin, Siow, Deanna, Wattenberg, Binks, Telang, Sucheta, Chesney, Jason
Publicado em 2009

Transient T cell depletion causes regression of melanoma metastases

Por Rasku, Mary Ann, Clem, Amy L, Telang, Sucheta, Taft, Beverly, Gettings, Kelly, Gragg, Hana, Cramer, Daniel, Lear, Sheron C, McMasters, Kelly M, Miller, Donald M, Chesney, Jason
Publicado em 2008

Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer

Por Clem, Brian F., O’Neal, Julie, Tapolsky, Gilles, Clem, Amy L., Imbert-Fernandez, Yoannis, Kerr, Daniel A., Klarer, Alden C., Redman, Rebecca, Miller, Donald M., Trent, John O., Telang, Sucheta, Chesney, Jason
Publicado em 2013

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

Por Telang, Sucheta, Rasku, Mary Ann, Clem, Amy L, Carter, Karen, Klarer, Alden C, Badger, Wesley R, Milam, Rebecca A, Rai, Shesh N, Pan, Jianmin, Gragg, Hana, Clem, Brian F, McMasters, Kelly M, Miller, Donald M, Chesney, Jason
Publicado em 2011